Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Respiratory Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1352644A discloses selective triazolo[4,3-a]quinazolin-5-ones as potent PDE4 inhibitors. This report analyzes synthesis routes, SAR, and supply chain advantages for respiratory drug development.
Patent CN102336705B reveals a novel amidation route for Roflumilast using activated esters, offering superior purity and cost-effective manufacturing for global supply chains.
Advanced patent CN113444001A details a cost-effective Ambroxol hydrochloride production route using o-nitrobenzyl bromide, ensuring high purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN1125815C details a novel synthesis for quinoline NK-3 antagonists offering higher yields and simplified purification for cost reduction in API manufacturing.
Patent CN102336703B details a green Bi2O3-catalyzed oxidation and HATU coupling route for Roflumilast, offering superior yield and supply chain reliability for global pharma buyers.